Burden of Mycoplasma genitalium and Bacterial Coinfections in a Population-Based Sample in New Mexico.
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
pubmed:
17
5
2021
medline:
15
12
2021
entrez:
16
5
2021
Statut:
ppublish
Résumé
In this population-based US study, the overall prevalence of Mycoplasma genitalium was 1.95% (95% confidence interval [CI], 1.62%-2.34%), declining from 6.12% (95% CI, 4.72%-7.92%) in women aged 21 to 24 years to 0.48% (95% CI, 0.25%-0.94%) in women aged 40 to 64 years. The prevalence of coinfections with Chlamydia trachomatis and Trichomonas vaginalis was low.
Identifiants
pubmed: 33993157
doi: 10.1097/OLQ.0000000000001472
pii: 00007435-202112000-00020
pmc: PMC8590705
mid: NIHMS1730785
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e186-e189Subventions
Organisme : NIAID NIH HHS
ID : U19 AI113187
Pays : United States
Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.
Déclaration de conflit d'intérêts
Conflict of Interest and Sources of Funding: C.M.W. reports receiving reagents and equipment from Roche Molecular Systems, Roche/Ventana Medical Systems, and Hologic through her institution and, outside of the submitted work, personal fees from BD. A.H. has received a speaker's fee from Astra Zeneca, Denmark, outside the submitted work. The remaining authors have nothing to disclose.
Références
Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sex Transm Dis 2013; 40:187–193.
Hoenderboom BM, van Benthem BHB, van Bergen J, et al. Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm Infect 2019; 95:300–306.
Reekie J, Donovan B, Guy R, et al. Risk of pelvic inflammatory disease in relation to chlamydia and gonorrhea testing, repeat testing, and positivity: A population-based cohort study. Clin Infect Dis 2018; 66:437–443.
Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:73–78.
Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: A meta-analysis. Clin Infect Dis 2015; 61:418–426.
Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359:765–766.
Cohen CR, Mugo NR, Astete SG, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 2005; 81:463–466.
Lewis J, Horner PJ, White PJ. Incidence of pelvic inflammatory disease associated with Mycoplasma genitalium infection: Evidence synthesis of cohort study data. Clin Infect Dis 2020; 71:2719–2722.
Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362–1366.
Cuzick J, Myers O, Hunt WC, et al. A population-based evaluation of cervical screening in the United States: 2008–2011. Cancer Epidemiol Biomarkers Prev 2014; 23:765–773.
Manhart LE, Holmes KK, Hughes JP, et al. Mycoplasma genitalium among young adults in the United States: An emerging sexually transmitted infection. Am J Public Health 2007; 97:1118–1125.
Huppert JS, Mortensen JE, Reed JL, et al. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35:250–254.
Bachmann LH, Kirkcaldy RD, Geisler WM, et al; MAGNUM Laboratory Working Group. Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations, and symptom resolution following treatment of urethritis. Clin Infect Dis 2020; 71:e624–e632.
Khosropour CM, Jensen JS, Soge OO, et al. High prevalence of vaginal and rectal Mycoplasma genitalium macrolide resistance among female sexually transmitted disease clinic patients in Seattle, Washington. Sex Transm Dis 2020; 47:321–325.
Torrone E, Papp J, Weinstock H; Centers for Disease Control and Prevention (CDC). Prevalence of Chlamydia trachomatis genital infection among persons aged 14–39 years—United States, 2007–2012. MMWR Morb Mortal Wkly Rep 2014; 63:834–838.
USPSTF. 2014. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/chlamydia-and-gonorrhea-screening . Accessed January 31, 2019.
Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24:131–141.
Moore MS, Golden MR, Scholes D, et al. Assessing trends in chlamydia positivity and gonorrhea incidence and their associations with the incidence of pelvic inflammatory disease and ectopic pregnancy in Washington state, 1988–2010. Sex Transm Dis 2016; 43:2–8.
Wiesenfeld HC, Manhart LE. Mycoplasma genitalium in women: Current knowledge and research priorities for this recently emerged pathogen. J Infect Dis 2017; 216(suppl_2):S389–S395.
Xiao L, Waites KB, Van Der Pol B, et al. Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-associated mutations in heterosexual African American couples in Alabama. Sex Transm Dis 2019; 46:18–24.
Getman D, Jiang A, O'Donnell M, et al. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol 2016; 54:2278–2283.
Romano SS, Jensen JS, Lowens MS, et al. Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis. Clin Infect Dis 2019; 69:113–120.
De Baetselier I, Kenyon C, Vanden Berghe W, et al. An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: Results from samples collected between 2015 and 2018. Sex Transm Infect 2021; 97:297–303.
Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010; 117:361–364.
Achilles SL, Reeves MF; Society of Family Planning. Prevention of infection after induced abortion: Release date October 2010: SFP guideline 20102. Contraception 2011; 83:295–309.